| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GYRE THERAPEUTICS, INC. | Chief Operating Officer | Common Stock | 700K | $525K | $0.75 | 01 Apr 2025 | Direct |
| GYRE THERAPEUTICS, INC. | Chief Operating Officer | Stock Option (Right to Buy) | 965K | 01 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | 01 Apr 2025 | 2 | $37.5K | 4 | Chief Operating Officer | 14 May 2025, 20:21 |
| GYRE | GYRE THERAPEUTICS, INC. | 24 Mar 2025 | 6 | $488K | 4 | Chief Operating Officer | 25 Apr 2025, 16:01 |
| GYRE | GYRE THERAPEUTICS, INC. | 07 Mar 2025 | 1 | $0 | 4 | Chief Operating Officer | 11 Mar 2025, 20:00 |
| GYRE | GYRE THERAPEUTICS, INC. | 20 Nov 2023 | 1 | $0 | 4 | Chief Operating Officer | 22 Nov 2023, 19:49 |
| CBIO | GYRE THERAPEUTICS, INC. | 30 Oct 2023 | 0 | $0 | 3 | Chief Operating Officer | 01 Nov 2023, 06:07 |